Aspinall vs. Gane was competitive for as long as it lasted. | Getty/UFC A little less than one full round of action was enough for the odds to shift for a potential rematch between Tom Aspinall and ...
UFC 321 was packed with drama and action. The fight card delivered what fans wanted, but the main event between Tom Aspinall and Ciryl Gane didn’t end the way everyone expected. An eye poke caused the ...
Dana White had his say on how the eye poke could affect the imminent rematch TOM ASPINALL has blasted Ciryl Gane for ignoring repeated warnings about outstretched fingers before his horrific double ...
The fallout from UFC 321 has been as heavy as the combined weight of the event's headliner title clash. Newly crowned heavyweight champion Tom Aspinall returned Saturday in Abu Dhabi to kick off his ...
Former UFC heavyweight Alistair Overeem insists Ciryl Gane should've been disqualified for eye poking Tom Aspinall. Overeem, who contested 67 professional MMA fights (20 in the UFC) during his ...
But it all came crashing down for the two UFC heavyweights when Gane poked both of Aspinall's eyes, causing the fight to be stopped and ruled a no-contestCredit: AFP After cracking Aspinall with a few ...
Chael Sonnen labeled Ciryl Gane a repeat offender after UFC 321 and said that Tom Aspinall should consider moving on from the rematch. Sonnen shared his thoughts on his YouTube channel after the ...
The Brit is set to undergo more tests in the coming days TOM ASPINALL is still worryingly unable to see out of his right eye following his anti-climactic showdown with Ciryl Gane. The Atherton ...
Champion Tom Aspinall and top-ranked Ciryl Gane couldn’t make it through the opening round of their heavyweight main event at UFC 321 inside Etihad Arena before the match was ruled a no-contest.
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
The latest price target for Alibaba Gr Hldgs (NYSE:BABA) was reported by Bernstein on October 10, 2025. The analyst firm set a price target for $200.00 expecting BABA to rise to within 12 months (a ...